Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6


Premenstrual dysphoric disorder: evidence for a new category for DSM-5.

Epperson CN, Steiner M, Hartlage SA, Eriksson E, Schmidt PJ, Jones I, Yonkers KA.

Am J Psychiatry. 2012 May;169(5):465-75.


Essential fatty acids for premenstrual syndrome and their effect on prolactin and total cholesterol levels: a randomized, double blind, placebo-controlled study.

Rocha Filho EA, Lima JC, Pinho Neto JS, Montarroyos U.

Reprod Health. 2011 Jan 17;8:2. doi: 10.1186/1742-4755-8-2.


Update on research and treatment of premenstrual dysphoric disorder.

Cunningham J, Yonkers KA, O'Brien S, Eriksson E.

Harv Rev Psychiatry. 2009;17(2):120-37. doi: 10.1080/10673220902891836. Review.


Premenstrual dysphoric disorder: burden of illness and treatment update.

Pearlstein T, Steiner M.

J Psychiatry Neurosci. 2008 Jul;33(4):291-301.


Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder: a meta-analysis.

Shah NR, Jones JB, Aperi J, Shemtov R, Karne A, Borenstein J.

Obstet Gynecol. 2008 May;111(5):1175-82. doi: 10.1097/AOG.0b013e31816fd73b.


The role of sex steroids in catamenial epilepsy and premenstrual dysphoric disorder: implications for diagnosis and treatment.

Guille C, Spencer S, Cavus I, Epperson CN.

Epilepsy Behav. 2008 Jul;13(1):12-24. doi: 10.1016/j.yebeh.2008.02.004. Epub 2008 Mar 17. Review.

Supplemental Content

Support Center